News, Analysis & Insights on Nutrition, Supplements, and Health
Special edition: Bone and joint health
Despite support from a prestigious Cochrane Review, many manufacturers to re-emphasize chondroitin and to use efficacious amounts in their supplements, says the President and CEO, Synutra Pure.
The tool was designed to bring market insight in the natural channel with the detail and depth once reserved to analysis in conventional channel data.
In response to increased global interest and having completed a dedicated production line in France, Horphag Research is extending the availability to additional US customers.
Special edition: Bone & Joint Health
Osteo Bi-flex has maintained its category-leading position by being open to embracing new ideas. That it, by staying flexible, an executive said.
Astaxanthin’s popularity has shown no signs of waning and one expert said there’s good reason. The science backing the ingredient continues to build in scope and power.
ANH: UK Court gives MHRA 'firm rap across the knuckles'
The UK Court of Appeal has ruled that glucosamine products above 1500 mg can be sold as food supplements, but has urged the UK medicines agency to look at the matter.